- Contractors
- Spaulding Clinical Research, LLC
Spaulding Clinical Research, LLC
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Spaulding Clinical Research has 2 federal contracts of $100,000 or more active since October 2023, with $11.5M obligated, from 1 agency. None is running now.
- Contracts
- 2 since FY2024$11,454,392 obligated, contracts of $100,000 or more
- Running now
- None2 ended in the last 12 months
- Biggest customer
- Food and Drug Administration$11.5M on 2 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- HERBKHMPKQN5Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $5,454,072 |
| FY2023 | $6,000,321 |
Running contracts
No contract of $100,000 or more is running now.
Who they work for
| Agency | Amount | Share |
|---|---|---|
| Food and Drug Administration2 contracts | $11,454,392 |
What they sell
| Industry | Amount | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts | $11,454,392 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.
Get new notices like Spaulding Clinical Research's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy